Lilly's Ambition to Extend its Legacy in Neurology

Big Pharma Eli Lilly & Co. (LLY) just announced yet another joint venture with a promising Biotech business: Evox Therapeutics, based in Oxford, England.  This time the focus is Neurology.

Eli Lilly currently does not have much of a neurological portfolio.  However, its history is rich in it.

Prozac was invented by Eli Lilly & Co. (LLY), and soon swept the world as the first highly effective drug for depression.

Zyprexa was extremely profitable until it went generic almost 10 years ago.  It took in sales of over 5 billion per year.

I buy and use the Eli Lilly drug that was known as Zyprexa along with Depakote that was sold by AbbVie Inc. (ABBV).  I've been injected with most of the drugs in the psychiatric arsenal.  And, Zyprexa and Depakote are the only ones I tolerate.

While a new drug would have to have a really good reputation to get me to try it, I would still love to see Eli Lilly & Co. (LLY) extend its proud tradition in neurological medicine.

Paul Wharton

Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind

This is What Free Market Pharma Can Do

Before the Coronavirus Pandemic, if a pharmaceutical company wanted to: develop, test, and win "approval" from controlling, government regulatory departments to sell a medicine, the process could typically take about 15 years.

Then Covid 19 hit.  It was contagious--a very deadly flu that spread around the whole world.  There was no known cure, or any treatment at first.  Finally, America woke up.  The United States government, led by President Donald Trump, slashed red tape, drastically rolled back regulations, and even restrained many government departments from getting involved at all.

On March 12th of this year, Eli Lilly & Co. (LLY) began a collaboration with AbCellera Biologics Inc. to co-develop antibody therapies for Covid 19, where Big Pharma, Eli Lilly, assumed the responsibility to manufacture and market the resulting medicine.

Just 81 days later, the product of private effort--a selected antibody that would have taken perhaps a decade to advance before--is entering human trials to determine its safety and tolerability.

June 1st marks a milestone in the history of medicine.  Instead of medical companies being overly worried about being blamed if something goes wrong, and bureaucrats depending on infallibility for their careers, finally in an atmosphere of reasonability: scientists, businessmen, and stockholders are liberated to advance one of the most important products of mankind.  Watch Eli Lilly & Co. (LLY).  This is what Free Market Pharma can do.

Paul Wharton

Special thanks to Eli Lilly & Co. (LLY) for inventing the fuel of my mind